Maria C Freire - Net Worth and Insider Trading
Maria C Freire Net Worth
The estimated net worth of Maria C Freire is at least $336,110 dollars as of 2023-03-30. Maria C Freire is the Director of Alexandria Real Estate Equities Inc and owns about 2,711 shares of Alexandria Real Estate Equities Inc (ARE) stock worth over $336,110. Details can be seen in Maria C Freire's Latest Holdings Summary section.
Transaction Summary of Maria C Freire
Maria C Freire Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maria C Freire owns 3 companies in total, including Exelixis Inc (EXEL) , Alexandria Real Estate Equities Inc (ARE) , and Biogen Inc (BIIB) .
Click here to see the complete history of Maria C Freire’s form 4 insider trades.
Insider Ownership Summary of Maria C Freire
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EXEL | Exelixis Inc | 2018-04-05 | director |
| ARE | Alexandria Real Estate Equities Inc | 2012-04-20 | director |
| BIIB | Biogen Inc | 2021-06-02 | director |
Maria C Freire Latest Holdings Summary
Maria C Freire currently owns a total of 1 stock. Maria C Freire owns 2,711 shares of Alexandria Real Estate Equities Inc (ARE) as of July 29, 2022, with a value of $336,110.
Latest Holdings of Maria C Freire
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARE | Alexandria Real Estate Equities Inc | 2022-07-29 | 2,711 | 123.98 | 336,110 |
Holding Weightings of Maria C Freire
Maria C Freire Form 4 Trading Tracker
According to the SEC Form 4 filings, Maria C Freire has made a total of 3 transactions in Alexandria Real Estate Equities Inc (ARE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Alexandria Real Estate Equities Inc is the sale of 2,600 shares on July 29, 2022, which brought Maria C Freire around $424,346.
Insider Trading History of Maria C Freire
- 1
Maria C Freire Trading Performance
Maria C Freire Ownership Network
Ownership Network List of Maria C Freire
Ownership Network Relation of Maria C Freire
Maria C Freire Owned Company Details
What does Exelixis Inc do?
Exelixis Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. Its lead molecule, cabozantinib, is indicated for treating patients with metastatic medullary thyroid cancer under the name Cometriq and for treating kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Who are the key executives at Exelixis Inc?
Maria C Freire is the director of Exelixis Inc. Other key executives at Exelixis Inc include CSO/EVP Disc & Trans Research Dana Aftab , EVP & Prod Dev & Med Aff &CMO Vicki L Goodman , and Sr. Vice President & Commercial Patrick J. Haley .
Exelixis Inc (EXEL) Insider Trades Summary
Over the past 18 months, Maria C Freire made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 212,286 shares made by Patrick J. Haley , a net sale of 167,860 shares made by Jeffrey Hessekiel , and a net sale of 162,500 shares made by Peter Lamb .
In summary, during the past 3 months, insiders sold 280,660 shares of Exelixis Inc (EXEL) in total and bought 0 shares, with a net sale of 280,660 shares. During the past 18 months, 952,958 shares of Exelixis Inc (EXEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 952,958 shares.
Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exelixis Inc Insider Transactions
Maria C Freire Mailing Address
Above is the net worth, insider trading, and ownership report for Maria C Freire. You might contact Maria C Freire via mailing address: C/o Alexandria Real Estate Equities, Inc, 26 North Euclid Avenue, Pasadena Ca 91101.
